HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer

Detalhes bibliográficos
Autor(a) principal: De Andrade, Warne Pedro [UNESP]
Data de Publicação: 2020
Outros Autores: Braga, Leticia Da Conceicao [UNESP], Goncales, Nikole Gontijo, Silva, Luciana Maria, Da Silva Filho, Agnaldo Lopes [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.3892/ol.2019.11095
http://hdl.handle.net/11449/196508
Resumo: Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy, with the presence of chemoresistance contributing to the poor prognosis. Heat Shock Proteins (HSPs) genes are activated in response to pathophysiological stress and serve a role in a variety of stages in carcinogenesis, acting primarily as anti-apoptotic agents and in chemotherapy resistance in a variety of tumor types. The current study evaluated the HSP gene expression profile in women with ovarian cancer (OC) and their correlation with clinical and pathological aspects of patients with OC. A total of 51 patients included in the current study were divided into four groups: Primary Epithelial Ovarian Cancer (EOC; n=14), metastatic EOC (n=11), ovarian serous cystadenoma (n=7) and no evidence of ovarian malignancy or control groups (n=19). RNA extraction and reverse transcription-quantitative (RT-q) PCR was then performed on the samples obtained. RT-qPCR was performed to compare TNF receptor associated protein 1 (TRAP]), heat shock protein family (HSP) HSPB1, HSPD1, HSPA1A and HSPA1L expression in primary and metastatic EOCs. TRAP], HSPB1, HSPD1, HSPA1A and HSPAlL gene expression did not differ among groups. HSPA1A, HSPA]L and TRAP] were revealed to be underexpressed in the primary and metastatic EOC groups, with HSPA1L exhibiting the lowest expression. TRAP] expression was higher in tumors at stages I/II compared with those at stages III/IV. No correlation was exhibited between HSP expression and age, menarche, menopause, parity, period after menopause initiation, cytoreduction, CA-125 or overall and disease-free survival. HSPA1A was negatively correlated with the risk of mortality from OC. The results indicated that the downregulation of HSPA1A, HSPA1L and TRAP] could be associated with the clinical prognostic features of women with EOC.
id UNSP_9156d7b6fdb095fbd2a4f35fda99203a
oai_identifier_str oai:repositorio.unesp.br:11449/196508
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancerovarian cancerprognosisresistance to chemotherapyheat shock proteinsgene expressionEpithelial ovarian cancer (EOC) is the most lethal gynecological malignancy, with the presence of chemoresistance contributing to the poor prognosis. Heat Shock Proteins (HSPs) genes are activated in response to pathophysiological stress and serve a role in a variety of stages in carcinogenesis, acting primarily as anti-apoptotic agents and in chemotherapy resistance in a variety of tumor types. The current study evaluated the HSP gene expression profile in women with ovarian cancer (OC) and their correlation with clinical and pathological aspects of patients with OC. A total of 51 patients included in the current study were divided into four groups: Primary Epithelial Ovarian Cancer (EOC; n=14), metastatic EOC (n=11), ovarian serous cystadenoma (n=7) and no evidence of ovarian malignancy or control groups (n=19). RNA extraction and reverse transcription-quantitative (RT-q) PCR was then performed on the samples obtained. RT-qPCR was performed to compare TNF receptor associated protein 1 (TRAP]), heat shock protein family (HSP) HSPB1, HSPD1, HSPA1A and HSPA1L expression in primary and metastatic EOCs. TRAP], HSPB1, HSPD1, HSPA1A and HSPAlL gene expression did not differ among groups. HSPA1A, HSPA]L and TRAP] were revealed to be underexpressed in the primary and metastatic EOC groups, with HSPA1L exhibiting the lowest expression. TRAP] expression was higher in tumors at stages I/II compared with those at stages III/IV. No correlation was exhibited between HSP expression and age, menarche, menopause, parity, period after menopause initiation, cytoreduction, CA-125 or overall and disease-free survival. HSPA1A was negatively correlated with the risk of mortality from OC. The results indicated that the downregulation of HSPA1A, HSPA1L and TRAP] could be associated with the clinical prognostic features of women with EOC.Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Vera Cruz Hosp, Oncol Serv, BR-30180090 Belo Horizonte, MG, BrazilSao Paulo State Univ, Sch Med, Dept Obstet & Gynecol, BR-18618687 Botucatu, SP, BrazilEzequiel Dias Fdn, Res & Dev Dept, Cellular Biol Serv, BR-30510010 Belo Horizonte, MG, BrazilMinas Gerais Fed Univ, Sch Med, Dept Obstet & Gynecol, 190 Alfredo Balena Ave, BR-30130100 Belo Horizonte, MG, BrazilSao Paulo State Univ, Sch Med, Dept Obstet & Gynecol, BR-18618687 Botucatu, SP, BrazilFAPEMIG: CDS-APQ-02373-17Spandidos Publ LtdVera Cruz HospUniversidade Estadual Paulista (Unesp)Ezequiel Dias FdnMinas Gerais Fed UnivDe Andrade, Warne Pedro [UNESP]Braga, Leticia Da Conceicao [UNESP]Goncales, Nikole GontijoSilva, Luciana MariaDa Silva Filho, Agnaldo Lopes [UNESP]2020-12-10T19:47:10Z2020-12-10T19:47:10Z2020-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article359-367http://dx.doi.org/10.3892/ol.2019.11095Oncology Letters. Athens: Spandidos Publ Ltd, v. 19, n. 1, p. 359-367, 2020.1792-1074http://hdl.handle.net/11449/19650810.3892/ol.2019.11095WOS:000508369500040Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengOncology Lettersinfo:eu-repo/semantics/openAccess2024-08-16T14:06:42Zoai:repositorio.unesp.br:11449/196508Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-16T14:06:42Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
title HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
spellingShingle HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
De Andrade, Warne Pedro [UNESP]
ovarian cancer
prognosis
resistance to chemotherapy
heat shock proteins
gene expression
title_short HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
title_full HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
title_fullStr HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
title_full_unstemmed HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
title_sort HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
author De Andrade, Warne Pedro [UNESP]
author_facet De Andrade, Warne Pedro [UNESP]
Braga, Leticia Da Conceicao [UNESP]
Goncales, Nikole Gontijo
Silva, Luciana Maria
Da Silva Filho, Agnaldo Lopes [UNESP]
author_role author
author2 Braga, Leticia Da Conceicao [UNESP]
Goncales, Nikole Gontijo
Silva, Luciana Maria
Da Silva Filho, Agnaldo Lopes [UNESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Vera Cruz Hosp
Universidade Estadual Paulista (Unesp)
Ezequiel Dias Fdn
Minas Gerais Fed Univ
dc.contributor.author.fl_str_mv De Andrade, Warne Pedro [UNESP]
Braga, Leticia Da Conceicao [UNESP]
Goncales, Nikole Gontijo
Silva, Luciana Maria
Da Silva Filho, Agnaldo Lopes [UNESP]
dc.subject.por.fl_str_mv ovarian cancer
prognosis
resistance to chemotherapy
heat shock proteins
gene expression
topic ovarian cancer
prognosis
resistance to chemotherapy
heat shock proteins
gene expression
description Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy, with the presence of chemoresistance contributing to the poor prognosis. Heat Shock Proteins (HSPs) genes are activated in response to pathophysiological stress and serve a role in a variety of stages in carcinogenesis, acting primarily as anti-apoptotic agents and in chemotherapy resistance in a variety of tumor types. The current study evaluated the HSP gene expression profile in women with ovarian cancer (OC) and their correlation with clinical and pathological aspects of patients with OC. A total of 51 patients included in the current study were divided into four groups: Primary Epithelial Ovarian Cancer (EOC; n=14), metastatic EOC (n=11), ovarian serous cystadenoma (n=7) and no evidence of ovarian malignancy or control groups (n=19). RNA extraction and reverse transcription-quantitative (RT-q) PCR was then performed on the samples obtained. RT-qPCR was performed to compare TNF receptor associated protein 1 (TRAP]), heat shock protein family (HSP) HSPB1, HSPD1, HSPA1A and HSPA1L expression in primary and metastatic EOCs. TRAP], HSPB1, HSPD1, HSPA1A and HSPAlL gene expression did not differ among groups. HSPA1A, HSPA]L and TRAP] were revealed to be underexpressed in the primary and metastatic EOC groups, with HSPA1L exhibiting the lowest expression. TRAP] expression was higher in tumors at stages I/II compared with those at stages III/IV. No correlation was exhibited between HSP expression and age, menarche, menopause, parity, period after menopause initiation, cytoreduction, CA-125 or overall and disease-free survival. HSPA1A was negatively correlated with the risk of mortality from OC. The results indicated that the downregulation of HSPA1A, HSPA1L and TRAP] could be associated with the clinical prognostic features of women with EOC.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-10T19:47:10Z
2020-12-10T19:47:10Z
2020-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3892/ol.2019.11095
Oncology Letters. Athens: Spandidos Publ Ltd, v. 19, n. 1, p. 359-367, 2020.
1792-1074
http://hdl.handle.net/11449/196508
10.3892/ol.2019.11095
WOS:000508369500040
url http://dx.doi.org/10.3892/ol.2019.11095
http://hdl.handle.net/11449/196508
identifier_str_mv Oncology Letters. Athens: Spandidos Publ Ltd, v. 19, n. 1, p. 359-367, 2020.
1792-1074
10.3892/ol.2019.11095
WOS:000508369500040
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Oncology Letters
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 359-367
dc.publisher.none.fl_str_mv Spandidos Publ Ltd
publisher.none.fl_str_mv Spandidos Publ Ltd
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128119426514944